precoated plates, ready to use

Timely Delivery

orders over $99.

99% Customer


360 Days

100% money back

Online Support 24/7

Secure System

Trastuzumab is a humanized monoclonal antibody which targets Her-2/neu receptor. Trastuzumab is approved for use in treating breast cancers and is being tested for other cancers that over expresses HER-2/neu.

Intended Use:
The KRIBIOLISA Trastuzumab ELISA is used as an analytical tool for quantitative determination of Trastuzumab in serum, plasma and cell culture supernatant.

The method employs the quantitative sandwich enzyme immunoassay technique. Antibodies to Trastuzumab are pre-coated onto microwells. Samples and standards are pipetted into microwells and human Trastuzumab present in the sample are bound by the capture antibody. Then, a HRP (horseradish peroxidase) conjugated anti-Trastuzumab antibody is pipetted and incubated. After washing microwells in order to remove any non-specific binding, the ready to use substrate solution (TMB) is added to microwells and color develops proportionally to the amount of Trastuzumab in the sample. Color development is then stopped by addition of stop solution. Absorbance is measured at 450 nm.
Product Specifications
Citations No
Pack Size 1 x 96 wells
Brand Krishgen Biosystems
Other Recommendation No
Reactivity or Species Trastuzumab (HERCEPTIN)
Made to Measure N/A